PTSD (n = 15) | Instrument, cut-off | No./total no. | Prevalence in % (95% CI) | ||||
    < 1 month | 1 month | 3 months | 6 months | 12 months | |||
Alarcon et al. [13] | PCL-C, ≥35 | 7/16 |     – | 43.7 (11.4–76.2) | – | – | – |
Bisson et al. [23] | TSQ, ≥6 | 338/3349 |     59.1 (52.8–65.4) | – | – | – | – |
Cunningham et al. [15] | MINI, DSM-IV criteria | 30/184 |     – | – | – | – | 16.3 (10.5–22.1) |
Elklit et al. [26] | HTQ, ≥3 on all scales | 26/118 |     – | – | – | 22.0 (13.5–30.5) | – |
Fein et al. [16] | CATS, ≥27 | 4/96 |     – | – | 5.8 (0.12–11.5) | – | – |
Hunt et al. [20] | CAPS, DSM-V criteria | 7/12 |     – | 58.3 (15.1–100) | – | – | – |
Johansen et al. [27] | PTSS-10a,b | 46/138 |     – | 33.3 (23.7–43.0)c | – | – | – |
Johansen et al. [28] | PTSS-10a,b | 20/70, 17/70, 19–70 |     – | 28.6 (16.0–41.1) | 24.3 (12.7–35.8) | – | 27.1 (14.9–39.3) |
Kleim et al. [24] | SCID, DSM-IV criteria | 49/205 |     – | – | – | 23.9 (17.2–30.6) | – |
McCart et al. [17] | TSCC, NR | 7/89 |     7.1 (1.85–12.4) | – | – | – | – |
Pailler et al. [18] | CATS, ≥27 | 3/158 |     – | – | – | 1.9 (3.8–12.7) | – |
Purtle et al. [19] | CTSQ, ≥5 | 31/47 |     66.0 (42.7–89.2) | – | – | – | – |
Roy-Byrne et al. [22] | CAPS, DSM-V criteria | 14/23, 7/23 |     – | 60.9 (29.0–92.8) | 30.4 (7.9–53.0) | – | – |
Sullivan et al. [21] | PC-PTSD, ≥3 | 33/87 |     37.9 (25.0–50.9) | – | – | – | – |
Walters et al. [25] | DTSd | NR |     – | 11 (NR) | – | 7.7 (NR) | – |
ASD (N = 5) | Instrument, cut-off | No./total no. | Prevalence in % (95% CI) | ||||
    < 1 week | 1 week | > 1 week |  | ||||
Boccelari et al. [14] | ASDS, > 36 | 221/541 |     – | 40.9 (35.5–46.2) | – |  |  |
Elklit et al. [26] | HTQ, ≥2 | 47/196 |     24.0 (17.1–30.8) | – | – |  |  |
Fein et al. [16] | ISRCe | 17/69 |     24.6 (12.9–36.3) | – | – |  |  |
Kleim et al. [24] | ASDS, NR | 37/222 |     – | – | 16.7 (11.3–22.0) |  |  |
Pailler et al. [18] | ISRC, NR | 46/394 |     – | 11.7 (8.3–15.0) | – |  |  |
Depression (N = 5) | Instrument, cut-off | No./total no. | Prevalence in % (95% CI) | ||||
    < 1 month | ≥ 1 month |  | |||||
Boccelari et al. [14] | PHQ, NR | 191/541 |     35.3 (30.3–40.3) | – |  |  |  |
Cunningham et al. [15] | MINI, DSM-IV criteria | 31/184 |     – | 16.8 (10.9–22.8) |  |  |  |
McCart et al. [17] | TSCC, NR | 5/89 |     5.1 (0.6–9.6) | – |  |  |  |
Pailler et al. [18] | CDI-SF, > 65 | 12/394 |     3.0 (1.3–4.8) | – |  |  |  |
Sullivan et al. [21] | PHQ-8, ≥10 | 36/87 |     41.4 (27.9–54.9) | – |  |  |  |